Innovative Technologies specializes in new drug discovery and bringing critical therapies to market by forming strategic partnerships.

ITL also produces a growing list of key synthetic intermediates for contract manufacturing, including Poly-L-Lysine and other pharmaceutical-grade synthetic amino acid polymers.

• ITL President Shares New Business Plan (05/28/09)
• ITL Awarded New Trademark for ADHD/Narcolepsy Drug (05/18/09)
• ITL Achieves Bulk Production of Poly-L-Lysine (05/01/09)
• New Employee at ITL (04/16/09)